Sanyuan Biotechnology: Shareholders holding more than 5% of shares decrease their holdings by 1 million shares. The implementation of the reduction plan has been completed.

San Yuan Biological announced that shareholder Lv Xi'an, who holds more than 5% of the shares, cumulatively reduced the company's holdings by 1 million shares through block trading from May 6 to May 11, 2026, accounting for 0.5% of the company's current total share capital. After this change in equity, their shareholding ratio decreased from 6.426% to 5.926%, reaching a multiple of 1% and the reduction plan has been completed. This reduction is consistent with previous disclosures, will not result in a change in control of the company, and will not have a significant impact on the company's operations.